Michael Christel

Michael Christel is Pharmaceutical Executive and Applied Clinical Trials' Managing Editor. He can be reached at mchristel@mmhgroup.com.


Rare Disease Research: It Pays to Engage

November 02, 2016

With pursuits in rare and orphan disease beginning to move more into the drug development mainstream, the opportunities and challenges in patient engagement and trial execution for these conditions are ever-evolving, as one strategy expert in the field discusses.

Q&A: Research Data Promise vs. Reality

June 20, 2016

Today’s convergence of health data and technology is fun to watch unfold, but a focused vision on system and process integration-and the framework for continuous enrichment-will be key to future lasting gains for clinical research.

Think Big on Outsourcing: A Network Approach for Small Biopharma

July 09, 2015

Proposed partnership model explores the value of establishing alliances between CROs and networks of small and emerging biopharma companies.

Q&A: The Future of Clinical Trial Data Sharing

June 04, 2015

Merck & Co. Chief Medical Officer Dr. Michael Rosenblatt speaks with Applied Clinical Trials about the significant opportunities and challenges of sharing clinical trial data and the progress so far in developing a framework that, if properly pursued, could help transform the future of research and clinical care.

New Approaches to Speeding Up Clinical Trials – What Works and What Doesn’t

May 27, 2015

The concept of increasing the speed and efficiency of clinical trials is a well understood and agreed upon priority of most clinical operations professionals.

The Patients 2 Trials Consortium

May 27, 2015

 Engaging and recruiting participants for clinical trials continues to be a struggle for the life sciences industry. However, emerging technology partnerships in the biopharma space may be providing hope in accelerating patient enrollment and reducing bottlenecks through a concentrated focus on target profiles.